Back
Chimerix 10K Form
Buy
53
CMRX
Chimerix
Last Price:
$3.33
Seasonality Move:
5.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | CMRX/Chimerix Quarterly |
| 2023-11-02 | 10Q | CMRX/Chimerix Quarterly |
| 2023-08-03 | 10Q | CMRX/Chimerix Quarterly |
| 2023-05-04 | 10Q | CMRX/Chimerix Quarterly |
| 2022-11-03 | 10Q | CMRX/Chimerix Quarterly |
| 2022-08-08 | 10Q | CMRX/Chimerix Quarterly |
Receive CMRX News And Ratings
See the #1 stock for the next 7 days that we like better than CMRX
CMRX Financial Statistics
Sales & Book Value
| Annual Sales: | $324K |
|---|---|
| Cash Flow: | $-20.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.51 |
| Price / Book: | 2 |
Profitability
| EPS (TTM): | -0.95000 |
|---|---|
| Net Income (TTM): | $-83.6M |
| Gross Margin: | $324K |
| Return on Equity: | -48.22% |
| Return on Assets: | -43.12% |
Chimerix Earnings Forecast
Key Chimerix Financial Ratios
-
The Gross Profit Margin over the past 8 years for CMRX is 100.00%.
-
The Selling, General & Administrative Expenses for CMRX have been equal to 7,592.90% of Gross Profit Margin.
-
The Research & Development expenses have been 21,230.86% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of CMRX is -25,337.96% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 7 years.
Chimerix Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CMRX |
| CUSIP: | 16934W |
| Website: | chimerix.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.33 |
| Quick Ratio: | 6.13 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |